Healthcare -
Biotechnology - NASDAQ - US
$ 0.5401
-1.85 %
$ 56.1 M
Market Cap
-1.17
P/E
UNCY - STOCK-BASED COMPENSATION
Stock-based Compensation UNCY - Unicycive Therapeutics, Inc.
1.77 M
LAST VALUE
35.25%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR